Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel disease

Dan Turner*, Victorien M. Wolters, Richard K. Russell, Valentina Shakhnovich, Aleixo M. Muise, Oren Ledder, Bo Ngan, Craig Friesen

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel disease'. Together they form a unique fingerprint.

Medicine & Life Sciences